BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33668117)

  • 81. The T Cell in Myeloma.
    Joshua D; Suen H; Brown R; Bryant C; Ho PJ; Hart D; Gibson J
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):537-542. PubMed ID: 27601001
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cytotoxic T lymphocytes and autoimmunity.
    Blanco P; Viallard JF; Pellegrin JL; Moreau JF
    Curr Opin Rheumatol; 2005 Nov; 17(6):731-4. PubMed ID: 16224251
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?
    Pettit AR; Thomas R
    Immunol Cell Biol; 1999 Oct; 77(5):420-7. PubMed ID: 10540208
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Induction of CD137 expression by viral genes reduces T cell costimulation.
    Wu M; Wong HY; Lin JL; Moliner A; Schwarz H
    J Cell Physiol; 2019 Nov; 234(11):21076-21088. PubMed ID: 31025383
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins.
    Simeoni L; Lindquist JA; Smida M; Witte V; Arndt B; Schraven B
    Immunol Rev; 2008 Aug; 224():215-28. PubMed ID: 18759929
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.
    Becher B; Bechmann I; Greter M
    J Mol Med (Berl); 2006 Jul; 84(7):532-43. PubMed ID: 16773356
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity.
    Moalem G; Gdalyahu A; Shani Y; Otten U; Lazarovici P; Cohen IR; Schwartz M
    J Autoimmun; 2000 Nov; 15(3):331-45. PubMed ID: 11040074
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Engineering Biomimetic Trogocytosis with Farnesylated Chemically Self-Assembled Nanorings.
    Wang Y; Rozumalski L; Kilic O; Lichtenfels C; Petersberg J; Distefano MD; Wagner CR
    Biomacromolecules; 2022 Dec; 23(12):5018-5035. PubMed ID: 36416233
    [TBL] [Abstract][Full Text] [Related]  

  • 90. FcγR-Mediated Trogocytosis 2.0: Revisiting History Gives Rise to a Unifying Hypothesis.
    Lindorfer MA; Taylor RP
    Antibodies (Basel); 2022 Jul; 11(3):. PubMed ID: 35892705
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Regulation of immune reactivity by intercellular transfer.
    Dhainaut M; Moser M
    Front Immunol; 2014; 5():112. PubMed ID: 24734030
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cell surface signaling molecules in the control of immune responses: a tide model.
    Zhu Y; Yao S; Chen L
    Immunity; 2011 Apr; 34(4):466-78. PubMed ID: 21511182
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies.
    Ochs J; Häusser-Kinzel S; Weber MS
    Nat Rev Immunol; 2023 Sep; 23(9):539-540. PubMed ID: 37491447
    [No Abstract]   [Full Text] [Related]  

  • 94. Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma.
    Brown R; Suen H; Favaloro J; Yang S; Ho PJ; Gibson J; Joshua D
    Oncoimmunology; 2012 Dec; 1(9):1658-1660. PubMed ID: 23264928
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Contextual Cell Death in Adaptive Immunity: Selecting a Winning Response.
    Herbert A
    Front Immunol; 2019; 10():2898. PubMed ID: 31921159
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Photo-Driven In Situ Solidification of Whole Cells through Inhibition of Trogocytosis for Immunotherapy.
    Liu H; Huang K; Zhang H; Liu X; Jiang H; Wang X
    Research (Wash D C); 2024; 7():0318. PubMed ID: 38384327
    [TBL] [Abstract][Full Text] [Related]  

  • 97. AMIS RBC antigen loss: nibble or devour?
    Mikdar M; Azouzi S
    Blood; 2024 Feb; 143(9):742-744. PubMed ID: 38421815
    [No Abstract]   [Full Text] [Related]  

  • 98. ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes.
    Lu Z; McBrearty N; Chen J; Tomar VS; Zhang H; De Rosa G; Tan A; Weljie AM; Beiting DP; Miao Z; George SS; Berger A; Saggu G; Diehl JA; Koumenis C; Fuchs SY
    Cell Metab; 2024 May; 36(5):1164-1167. PubMed ID: 38604169
    [No Abstract]   [Full Text] [Related]  

  • 99. Editorial: Defects in Regulation: How, Where and When the Immune System Can Go Wrong.
    Rijkers GT; Riccardi C; Kroese FGM
    Front Immunol; 2021; 12():746418. PubMed ID: 34484250
    [No Abstract]   [Full Text] [Related]  

  • 100. NK-cell trogocytosis of CD19 antigen: a rare B-ALL MRD mimicker.
    Panda D; Pathak A; Tejwani N; Mehta A
    Blood Res; 2022 Dec; 57(4):249. PubMed ID: 36579484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.